Thryv Therapeutics Inc.
a clinical-stage biotechnology company developing precision therapies for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.
Canada
Amount raised
$30M
Round
Series B
Date raised
November 3, 2026
Founded
—
CompanyThryv Therapeutics Inc.
LocationCanada
InvestorsInClin
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Thryv Therapeutics Inc.
a clinical-stage biotechnology company developing precision therapies for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.
- How much did Thryv Therapeutics Inc. raise?
- Thryv Therapeutics Inc. raised $30M in a Series B round on November 3, 2026. Investors include InClin.
- Who founded Thryv Therapeutics Inc.?
- No founder is listed for Thryv Therapeutics Inc. yet.
- Where is Thryv Therapeutics Inc. based?
- Thryv Therapeutics Inc. is based in Canada.